BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15705944)

  • 1. How to avoid CIN: guidelines from the European Society of Urogenital Radiology.
    Thomsen HS
    Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i18-22. PubMed ID: 15705944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Society of Urogenital Radiology guidelines on administering contrast media.
    Morcos SK; Thomsen HS;
    Abdom Imaging; 2003; 28(2):187-90. PubMed ID: 12592465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines.
    Thomsen HS; Morcos SK
    Br J Radiol; 2003 Aug; 76(908):513-8. PubMed ID: 12893691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media.
    Thomsen HS
    Eur J Radiol; 2006 Dec; 60(3):307-13. PubMed ID: 16965884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESUR guidelines on contrast media.
    Thomsen HS; Morcos SK;
    Abdom Imaging; 2006; 31(2):131-40. PubMed ID: 16447092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Society of Urogenital Radiology guidelines on contrast media application.
    Thomsen HS;
    Curr Opin Urol; 2007 Jan; 17(1):70-6. PubMed ID: 17143114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-induced nephropathy--prevention and risk reduction.
    Lameire NH
    Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of contrast-induced nephropathy: an overview.
    Ellis JH; Cohan RH
    Radiol Clin North Am; 2009 Sep; 47(5):801-11, v. PubMed ID: 19744595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
    Reddan D; Fishman EK
    Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum creatinine measurements: evaluation of a questionnaire according to the ESUR guidelines.
    Zähringer C; Potthast S; Tyndall AJ; Bongartz G; Hohmann J
    Acta Radiol; 2015 May; 56(5):628-34. PubMed ID: 24867223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
    Stacul F; van der Molen AJ; Reimer P; Webb JA; Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clement O; Heinz-Peer G;
    Eur Radiol; 2011 Dec; 21(12):2527-41. PubMed ID: 21866433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and therapy strategies for contrast-induced nephropathy.
    Toprak O; Cirit M
    Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent issues in contrast-induced nephropathy.
    Kitajima K; Maeda T; Watanabe S; Sugimura K
    Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR).
    Morcos SK; Thomsen HS; Webb JA
    Eur Radiol; 1999; 9(8):1602-13. PubMed ID: 10525875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.